Flecainide acetate and Atrovent drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flecainide acetate (flecainide acetate) and Atrovent (ipratropium bromide). Common drug interactions include abdominal mass among females and headache among males.

The phase IV clinical study analyzes what interactions people have when they take Flecainide acetate and Atrovent. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Flecainide acetate?

Flecainide acetate has active ingredients of flecainide acetate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 7,176 Flecainide acetate users. Check the latest studies of Flecainide acetate.

What is Atrovent?

Atrovent has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 33,210 Atrovent users. Check the latest studies of Atrovent.



On Jul, 11, 2026

45 people who take Flecainide acetate and Atrovent together, and have interactions are studied.

Flecainide acetate and Atrovent drug interactions.

What are the common drug interactions of Flecainide Acetate and Atrovent, by gender? *:

female:

  1. Abdominal mass (localized enlargement or swelling in the human abdomen)
  2. Abdominal pain
  3. Acquired macroglossia (large tongue)
  4. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  5. Acute respiratory failure
  6. Anticonvulsant drug level above therapeutic
  7. Anxiety
  8. Aortic valve sclerosis (narrowing of the aortic valve)
  9. Atrial hypertrophy (a condition where the left atrium or right atrium of the heart is larger than would be expected)
  10. Atrial tachycardia (rhythm disturbance that arises in the atria)

male:

  1. Headache (pain in head)
  2. Cough
  3. Migraine (headache)
  4. Prostate infection
  5. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Fatigue (feeling of tiredness)
  8. Pain
  9. Pneumonia
  10. Alanine aminotransferase increased

What are the common drug interactions of Flecainide Acetate and Atrovent, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Gallbladder disorder
  2. Influenza like illness
  3. Nodal arrhythmia (an irregular heart beat originating from within the atrioventricular node)
  4. Pulmonary hypertension (increase in blood pressure in the lung artery)
  5. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  6. Fatigue (feeling of tiredness)
  7. Headache (pain in head)
  8. Pain
  9. Pneumonia

50-59:

  1. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  2. Urinary tract infection
  3. Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
  4. Fall
  5. Head injury
  6. Loss of consciousness

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Headache (pain in head)
  3. International normalised ratio increased
  4. Asthenia (weakness)
  5. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  6. Fall
  7. Drug resistance (reduction in effectiveness of a drug)
  8. Prostate infection
  9. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  10. Anaemia (lack of blood)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 11 people, 24.44%
  2. Stress And Anxiety: 3 people, 6.67%
  3. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 6.67%
  4. Muscle Strain (an injury to a muscle in which the muscle fibres tear): 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Flecainide acetate and Atrovent?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Flecainide acetate and Atrovent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Flecainide acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Atrovent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flecainide acetate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Atrovent and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on flecainide acetate and ipratropium bromide (the active ingredients of Flecainide acetate and Atrovent, respectively), and Flecainide acetate and Atrovent (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: